| Lora Louise Hummel-koch, RPH | |
|
1430 North Ave, Spearfish, SD 57783 | |
| (605) 642-0650 | |
| (605) 642-0263 |
| Full Name | Lora Louise Hummel-koch |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1430 North Ave, Spearfish, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265727424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4539 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lora Louise Hummel-koch, RPH 1430 North Ave, Spearfish, SD 57783-1593 Ph: (605) 642-0650 | Lora Louise Hummel-koch, RPH 1430 North Ave, Spearfish, SD 57783 Ph: (605) 642-0650 |
News Archive
Birner Dental Management Services, Inc., operators of PERFECT TEETH® dental practices, announced results for the year and quarter ended December 31, 2009. For the year ended December 31, 2009, revenue increased $557,000, or 0.9%, to $59.6 million. The Company's earnings before interest, taxes, depreciation, amortization and non-cash expense associated with stock-based compensation ("Adjusted EBITDA") increased $101,000, or 1.5%, to $6.9 million.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
An international research team has confirmed the mechanism by which the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Their article titled, "SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling," is published in the journal Proceedings of the National Academy of Sciences.
A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.
› Verified 6 days ago
Mary Ables, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 1st Ave, Spearfish, SD 57783 Phone: 605-642-3025 | |
Krista Stevens, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1430 North Ave, Spearfish, SD 57783 Phone: 605-642-0650 | |
April Leanna Owen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Suite #2, Spearfish, SD 57783 Phone: 605-642-3039 Fax: 605-644-0744 | |
Chelsea Rendleman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Spearfish, SD 57783 Phone: 605-642-3039 Fax: 605-644-0744 | |
Mr. Don G Abrahamson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Suite #2, Spearfish, SD 57783 Phone: 605-642-4747 | |
Austin James Kott, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 1st Ave, Spearfish, SD 57783 Phone: 605-642-3025 Fax: 605-642-1832 | |
Mr. Kent Stephen Kennon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 North Ave, Safeway Pharmacy, Spearfish, SD 57783 Phone: 605-342-3909 |